OOIR: Observatory of International Research

Papers

(The H4-Index of Archiv der Pharmazie is 26. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Selective cytotoxicity of ent‐kaurene diterpenoids isolated from Baccharis lateralis and Baccharis retusa (Asteraceae)	220
Structure‐guided identification of a selective sulfonamide‐based inhibitor targeting the human carbonic anhydrase VA isoform	208
Combating DC‐SIGN‐mediated SARS‐CoV‐2 dissemination by glycan‐mimicking polymers	75
Cover Picture: Arch Pharm (1/2024)	68
What doesn't fit is made to fit: Pim‐1 kinase adapts to the configuration of stilbene‐based inhibitors	58
GOAT rs10096097 and CREB1 rs6740584 single nucleotide polymorphisms are associated with type 2 diabetes mellitus in Egyptians	51
Fabrication of sulfobutylether‐β‐cyclodextrin/glabridin inclusion complex for promoting bioactivities	46
Discovery of xanthone‐based nitric oxide donors targeting biofilm clearance	45
Synthesis and biological evaluation of salophen nickel(II) and cobalt(III) complexes as potential anticancer compounds	44
Synthesis of novel pyrimido[4,5‐b]quinoline derivatives as dual EGFR/HER2 inhibitors as anticancer agents	42
In vitro antiviral activity of favipiravir and its 6‐ and 3‐O‐substituted derivatives against coronavirus: Acetylation leads to improvement of antiviral activity	41
Piperlongumine and its derivatives against cancer: A recent update and future prospective	40
Review on the pharmacological effects and pharmacokinetics of scutellarein	40
Implication of in silico studies in the search for novel inhibitors against SARS‐CoV‐2	39
Synthesis, density functional theory calculation, molecular docking studies, and evaluation of novel 5‐nitrothiophene derivatives for anticancer activity	38
A novel class for carbonic anhydrases inhibitors and evaluation of their non‐zinc binding	38
Synthesis, antimycobacterial, cytotoxicity, anti‐inflammatory, in silico studies and molecular dynamics of pyrazole‐embedded thiazolidin‐4‐one hybrids	34
Design, synthesis, and activity evaluation of novel multitargeted l‐tryptophan derivatives with powerful antioxidant activity against Alzheimer's disease	32
Design, synthesis, cytotoxicity, and molecular docking studies of novel thiazolyl–hydrazone derivatives as histone lysine acetyl‐transferase inhibitors and apoptosis inducers	32
Chemistry of heterocycles as carbonic anhydrase inhibitors: A pathway to novel research in medicinal chemistry review	30
Functional combination of resveratrol and tamoxifen to overcome tamoxifen‐resistance in breast cancer cells	28
NorA Efflux Pump Inhibitors: Expanding SAR Knowledge of Pyrazolo[4,3‐c][1,2]benzothiazine 5,5‐Dioxide Derivatives	27
Thiazole‐based SARS‐CoV‐2 protease (COV M^pro) inhibitors: Design, synthesis, enzyme inhibition, and molecular modeling simulations	27
Aripiprazole as an Inhibitor of the EGFR/PI3K/AKT Signaling Pathway and Sensitizer of MPA Suppressed Progestin‐Resistant Endometrial Cancer Cells	26
Cover Picture: Arch Pharm (2/2024)	26